2X Blend is a balanced blend of Tesamorelin (10mg) and Ipamorelin (2mg) designed to investigate synergistic effects on growth hormone (GH) secretion pathways in experimental models, with applications in metabolic and endocrine research.
Tesamorelin, a GHRF analog, has been studied for its role in stimulating GH release and modulating lipolytic activity in controlled laboratory settings.
Ipamorelin selectively binds to the ghrelin receptor, exhibiting GH-releasing activity with limited impact on ACTH or prolactin secretion in non-clinical research models.
This combination is under investigation for its potential to influence adipose metabolism, protein synthesis signaling, and tissue regeneration mechanisms in vitro and in vivo studies.
This dual-peptide formulation provides a research tool for evaluating combined GH secretagogue effects on metabolic, endocrine, and cellular repair pathways.